Dopamine

• Cannabinoids and monoaminergic system: implications for learning and memory (03 Sep 2024)
  
• DNA methylation at cannabinoid type 1 and dopamine D2 receptor genes in saliva samples of psychotic subjects: Is there an effect of Cannabis use? (02 Sep 2024)
  
• The Role of Cannabinoid Type 2 Receptors in Parkinson’s Disease (27 Aug 2024)
  
• Role of Cannabinoid CB2 Receptor in Alcohol Use Disorders: From Animal to Human Studies (25 Aug 2024)
  
• Cannabinoid type-2 receptors: An emerging target for regulating schizophrenia-relevant brain circuits (25 Aug 2024)
  
• A helping HAND: therapeutic potential of MAGL inhibition against HIV-1-associated neuroinflammation (24 May 2024)
  
• Role of the Endocannabinoid System in Metabolic Control Processes and in the Pathogenesis of Metabolic Syndrome: An Update (27 Feb 2023)
  
• Quality of Life and a Surveillant Endocannabinoid System (05 Sep 2022)
  
• CB2 Receptor Involvement in the Treatment of Substance Use Disorders (05 Sep 2022)
  
• The systems medicine of cannabinoids in pediatrics: the case for more pediatric studies (27 Aug 2022)
  
• New Insights in the Involvement of the Endocannabinoid System and Natural Cannabinoids in Nicotine Dependence (27 Aug 2022)
  
• Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition (13 Aug 2022)
  
• Medicinal Cannabis and Central Nervous System Disorders (31 Jul 2022)